‘Youth can be given priority over older ones’: Delhi HC amid shortage of COVID vaccines, black fungus medicine

 Hearing a batch of petitions in regards to the management of COVID-19 crisis in Delhi and drugs shortage against Mucormycosis/black fungus, the Delhi High Court on Tuesday noted that those with a better chance of survival and the younger age group be given priority over older ones who have lived their lives.

“We have to secure our future for that we need to vaccinate our younger generation and here we are giving priority to 60 plus who have lived their lives. It is the younger lot which is the future, we are on our way out,” Justice Sanghi said.

Expressing unhappiness over Centre’s COVID vaccination policy, Justice Sanghi said that during the second wave of the coronavirus, the younger generation was affected the most and they were the ones who are not getting the vaccine doses.

“I don’t understand this vaccination policy at all. I can speak for myself… You have announced the vaccination policy for 18 to 44 years old persons now but you don’t have vaccines. Then why you have to announce and make a declaration when you don’t have the vaccines? We have to invest in the future and we are sidelining them,” Justice Sanghi said.

“We have to chose the younger one because an 80-year-old person has lived his live and he will not take the country forward. Ideally, we should be able to save everyone but if we have to chose, we have to save younger people,” the Delhi HC judge said.

Expressing displeasure over the shortage of medicines needed for the treatment of black fungus, the court said that Liposomal Amphotericin-B is in shortage in the country for two weeks now. The court said that it is high time for ICMR to issue guidelines in regards to the treatment of black fungus disease.

The Delhi high court also said that the government can give exception in drug policy for those serving the nation in high position or whose safety is necessary for pivotal roles they play.

The Delhi HC directed the Centre to form a policy on the distribution of Liposomal Amphotericin B to treat black fungus, spill out the priority of patients.

The court further asked the central governmnet to take the policy decision on the distribution of medicine Liposomal Amphotericin B drug, used for treating black fungus (mucormycosis).

Union Minister for Chemicals and Fertilizers Shri DV Sadananda Gowda on May 27 announced that the additional 80,000 vials of Amphotericin-B, used in the treatment for Mucormycosis have been allocated to all the states/UTs and central institutions.

As the nation is trying its best to tackle the deadly second wave of COVID-19 disease, Mucormycosis, a fungal infection, is being reported in some coronavirus patients during or post recovery.

As per the statement released by the union health ministry, “Mucormycosis or black fungus is a complication caused by fungal infection. People catch mucormycosis by coming in contact with the fungal spores in the environment. It can also develop on the skin after the fungus enters the skin through a cut, scrape, burn, or other type of skin trauma. The disease is being detected among patients who are recovering or have recovered from COVID-19. Moreover, anyone who is diabetic and whose immune system is not functioning well needs to be on the guard against this.”


The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies